Evidence map›Paper›PMID 38182565›Full record

ArticleNature communications2024

Enhancing geometric representations for molecules with equivariant vector-scalar interactive message passing.

Yusong Wang, Tong Wang, Shaoning Li, Xinheng He, Mingyu Li, Zun Wang, Nanning Zheng, Bin Shao, Tie-Yan Liu

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yusong Wang *Microsoft Research AI4Science, 100080, Beijing, China.
Tong Wang *Microsoft Research AI4Science, 100080, Beijing, China. watong@microsoft.com.ORCID http://orcid.org/0000-0002-9483-0050
Shaoning Li *Microsoft Research AI4Science, 100080, Beijing, China.
Xinheng HeMicrosoft Research AI4Science, 100080, Beijing, China.
Mingyu LiMicrosoft Research AI4Science, 100080, Beijing, China.
Zun WangMicrosoft Research AI4Science, 100080, Beijing, China.ORCID http://orcid.org/0000-0002-8763-8327
Nanning ZhengNational Key Laboratory of Human-Machine Hybrid Augmented Intelligence, National Engineering Research Center for Visual Information and Applications, and Institute of Artificial Intelligence and Robotics, Xi'an Jiaotong University, 710049, Xi'an, China.
Bin ShaoMicrosoft Research AI4Science, 100080, Beijing, China. binshao@microsoft.com.ORCID http://orcid.org/0000-0002-9790-5687
Tie-Yan LiuMicrosoft Research AI4Science, 100080, Beijing, China.ORCID http://orcid.org/0000-0002-0476-8020

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Geometric deep learning has been revolutionizing the molecular modeling field. Despite the state-of-the-art neural network models are approaching ab initio accuracy for molecular property prediction, their applications, such as drug discovery and molecular dynamics (MD) simulation, have been hindered by insufficient utilization of geometric information and high computational costs. Here we propose an equivariant geometry-enhanced graph neural network called ViSNet, which elegantly extracts geometric features and efficiently models molecular structures with low computational costs. Our proposed ViSNet outperforms state-of-the-art approaches on multiple MD benchmarks, including MD17, revised MD17 and MD22, and achieves excellent chemical property prediction on QM9 and Molecule3D datasets. Furthermore, through a series of simulations and case studies, ViSNet can efficiently explore the conformational space and provide reasonable interpretability to map geometric representations to molecular structures.

Identifiers

PMID38182565
PMCPMC10770089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.